I see a new risk that could break the 2026 growth story of Taiwan Semiconductor Manufacturing Company. HBM demand is squeezing supply, which could push Q1 2026 DRAM/NAND prices up by up to 55%–60% for DRAM and 33%–38% for NAND. So what? Smartphones were 30% of Q3 revenue. Higher handset prices could cool consumer demand in 2026, leading to disappointments from a guidance perspective.

Levi Strauss is initiated at a "Buy," driven by strong earnings growth, buybacks, and renewed focus on its core brand. LEVI is divesting non-core brands like Dockers, streamlining operations, and boosting its balance sheet with a $311 million cash infusion. Core Levi's brand posted 6.4% y/y organic net revenue growth, with Signature line up 21% and Asia sales rising 12% FX-neutral.

Microsoft shares gain as Office 365 subscriptions accelerate, with commercial and consumer growth, higher-tier uptake, and AI tools boosting revenue per user.

Broadcom (AVGO) stock has declined by 16.9% over 21 trading days. This recent drop expresses heightened worries concerning China's AI hardware risks alongside AI-driven margin compression.

We believe Ardent Health (ARDT) stock deserves attention: It is growing, generating cash, and is priced significantly below its valuation. Companies like this can utilize cash to drive further revenue growth or distribute it to their shareholders via dividends or buybacks.

Here's a quiz question for you. Which S&P 500 company delivered the highest stock gains, percentage-wise, in 2025?

OLN cuts Q4 2025 adjusted EBITDA outlook to about $67M after Freeport disruptions and softer pipeline chlorine demand hit results.

Viking Therapeutics completes enrollment in a phase I maintenance study of VK2735, testing flexible oral and injectable dosing after initial weight loss in obese adults.

ADEA and ACRE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 9th, 2026.

Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.

Regions Financial (RF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The PNC Financial Services Group (PNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

M&T Bank (MTB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BOK Financial (BOKF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

State Street (STT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

For many income-oriented investors, buying dividend stocks means looking for utilities names and real estate investment trusts (REITs). These companies typically offer consistent payouts for regular income, and some of the highest yields

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against F5, Inc. (“F5” or “the Company”) (NASDAQ: FFIV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 28, 2024 and October 27, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before February 17, 2026.

WASHINGTON--(BUSINESS WIRE)--KeifeRx, a privately held biotechnology company developing disease-modifying therapies for neurodegenerative disorders, today announced that it has entered into a research collaboration and option agreement with Amneal Pharmaceuticals to support the pre-IND development of KFRX06, KeifeRx's preclinical candidate designed to inhibit leucine-rich repeat kinase 2 (LRRK2), a gene strongly implicated in Parkinson's disease biology. Under the agreement, KeifeRx will conduc.

Semiconductor sales hit a record in November, with NVDA, MU, CRDO and ASYS set to gain from booming AI demand.

Super Micro Computers plans to push beyond data centers with AI PCs, edge and consumer systems, targeting $36 billion in revenues by FY26 and new growth avenues.